Generated by AI
Azitra Inc. is a clinical-stage biopharmaceutical company focused on precision dermatology. The company develops topical live biotherapeutic products and engineered protein-based therapeutics designed to address skin diseases by working with the skin microbiome. Its platform combines synthetic biology, microbial engineering, and protein design to create treatments for dermatologic conditions, including rare and hard-to-treat disorders. Azitra Inc. also uses a proprietary microbial library and data-driven screening tools to identify bacterial strains with therapeutic potential. The company’s current product portfolio includes investigational candidates aimed at dermatology and skin-barrier disorders, positioning Azitra Inc. within the specialized market for microbiome-based skin treatments and targeted dermatologic therapeutics.
Website21 Business Park Drive
Branford, CT, 06405
United States
The latest articles about AZTR.
Summary of Nov 2's posts. Generated by AI.
Summary of Nov 2's posts. Generated by AI.
Summary of Nov 2's posts. Generated by AI.
Investors talking about AZTR also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.